These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma. Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423 [TBL] [Abstract][Full Text] [Related]
23. Lessons learned from diffuse intrinsic pontine glioma: how a terrible disease forced us to think better. Kieran MW Neuro Oncol; 2017 Aug; 19(8):1017-1018. PubMed ID: 28541486 [No Abstract] [Full Text] [Related]
24. Panobinostat active against diffuse intrinsic pontine glioma. Bagcchi S Lancet Oncol; 2015 Jun; 16(6):e267. PubMed ID: 25971867 [No Abstract] [Full Text] [Related]
25. The emerging role of NG2 in pediatric diffuse intrinsic pontine glioma. Yadavilli S; Scafidi J; Becher OJ; Saratsis AM; Hiner RL; Kambhampati M; Mariarita S; MacDonald TJ; Codispoti KE; Magge SN; Jaiswal JK; Packer RJ; Nazarian J Oncotarget; 2015 May; 6(14):12141-55. PubMed ID: 25987129 [TBL] [Abstract][Full Text] [Related]
26. Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location. Karremann M; Gielen GH; Hoffmann M; Wiese M; Colditz N; Warmuth-Metz M; Bison B; Claviez A; van Vuurden DG; von Bueren AO; Gessi M; Kühnle I; Hans VH; Benesch M; Sturm D; Kortmann RD; Waha A; Pietsch T; Kramm CM Neuro Oncol; 2018 Jan; 20(1):123-131. PubMed ID: 29016894 [TBL] [Abstract][Full Text] [Related]
27. Superselective intracerebral catheterization for administration of oncolytic virotherapy in a case of diffuse intrinsic pontine glioma. Carceller F; Aleu A; Casasco A; Guimaraens L; López-Pino MA; Madero L; Ramírez M J Pediatr Hematol Oncol; 2014 Oct; 36(7):e430-2. PubMed ID: 24327128 [TBL] [Abstract][Full Text] [Related]
28. Biopsy for diffuse intrinsic pontine glioma: a reappraisal. Kieran MW; Goumnerova LC; Prados M; Gupta N J Neurosurg Pediatr; 2016 Sep; 18(3):390-1. PubMed ID: 27153377 [No Abstract] [Full Text] [Related]
29. Diffuse intrinsic pontine glioma: a clinic in Mexico, social media, and unpublishable data. Bouche G; Bouffet E; Vandeborne L; Capistrano R; André N Lancet Oncol; 2021 May; 22(5):595-596. PubMed ID: 33932371 [No Abstract] [Full Text] [Related]
30. Behavioural changes caused by diffuse intrinsic pontine glioma. Hamamoto Filho PT; Magro IB; Zanini MA Rev Assoc Med Bras (1992); 2018 Jul; 64(7):581-582. PubMed ID: 30365657 [No Abstract] [Full Text] [Related]
31. Tissue sampling in diffuse intrinsic pontine glioma (DIPG) at progression. Castañeda Heredia A; Puerta Roldan P; Guillen Quesada A; Sunol Capella M; de Torres Gomez-Pallete C; Muchart J; Cruz Martinez O; Mora J; Morales La Madrid A Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28233413 [No Abstract] [Full Text] [Related]
32. Neuro-oncology: New therapeutic targets for diffuse intrinsic pontine glioma. Ridler C Nat Rev Neurol; 2017 Apr; 13(4):196. PubMed ID: 28303929 [No Abstract] [Full Text] [Related]
33. Leptomeninges as a site of relapse in locally controlled, diffuse pontine glioma with review of literature. Singh S; Bhutani R; Jalali R Childs Nerv Syst; 2007 Jan; 23(1):117-21. PubMed ID: 16983574 [TBL] [Abstract][Full Text] [Related]
34. A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas. Hummel TR; Salloum R; Drissi R; Kumar S; Sobo M; Goldman S; Pai A; Leach J; Lane A; Pruitt D; Sutton M; Chow LM; Grimme L; Doughman R; Backus L; Miles L; Stevenson C; Fouladi M; DeWire M J Neurooncol; 2016 Mar; 127(1):53-61. PubMed ID: 26626490 [TBL] [Abstract][Full Text] [Related]